Health
Medical
Cancer Prevention

VolitionRX

$3.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-2.27%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VolitionRX and other stocks, options, ETFs, and crypto commission-free!

About

VolitionRX Limited Common Stock, also called VolitionRX, is a multi-national life sciences company. It engages in the development of blood-based cancer tests to help diagnose a range of cancers. Read More Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.

Employees
Headquarters
Singapore, Central Singapore
Founded
2010
Market Cap
107.90M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
91.91K
High Today
$3.19
Low Today
$2.98
Open Price
$3.11
Volume
23.85K
52 Week High
$3.45
52 Week Low
$1.44

Collections

Health
Medical
Cancer Prevention
Asia (Non-China)
Asia

News

Seeking AlphaMar 14

VolitionRX Ltd. (VNRX) CEO Cameron Reynolds on Q4 2018 Results - Earnings Call Transcript

VolitionRX Ltd. (NYSEMKT:VNRX) Q4 2018 Earnings Conference Call March 14, 2019 8:30 AM ET Company Participants Scott Powell - EVP, IR Cameron Reynolds - President & CEO Conference Call Participants Mark Breidenbach - Oppenheimer Jason McCarthy - Maxim Group Bruce Jackson - The Benchmark Company Brian Marckx - Zacks Investment Research Operator Good morning ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2018 Earnings Conference Cal...

27

Earnings

-$0.17
-$0.15
-$0.13
-$0.11
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.13 per share
Actual
-$0.11 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.